고지방/고콜레스테롤 식이 랫트 모델에서 홍삼에 의한 고중성지방혈증 개선 효과
Effect of Korean Red Ginseng on Hypertriglyceridemia in High Fat/high Cholesterol Diet Rat Model
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Korean Red Ginseng (RG) are used as a traditional treatment for improve blood circulation. This experimental study was designed to investigate the inhibitory effects of Korean red ginseng on lipid metabolism in high fat/cholesterol diet (HFCD)-induced hypertriglyceridemia. Sprague Dawley rats were fed the HFCD diet with/without fluvastatin (Flu, positive control) 3 mg/kg/day, and RG 125 or 250 mg/kg/day, respectively. All groups received regular diet or HFCD diet, respectively, for 13 weeks. The last three groups treatment of Flu and RG 125, and RG 250 orally for a period of 9 weeks. Group 1, reular diet; group 2, HFCD diet; group 3, Flu + HFCD diet; group 4, RG 125 + HFCD diet; group 5, RG 250 + HFCD diet. As a result, treatment with low or high doses of RG markedly attenuated plasma levels of triglycerides and augmented plasma levels of high-density lipoprotein (HDL) in HFCD-fed rats. RG and Flu also led to an increase in lipoprotein lipase activity in the HFCD group. On the other hand, RG and Flu led to an decrease in fatty acid synthase and free fatty acid activity in the HFCD group. Treatment with RG suppressed increased expressions of PPAR-α and AMPK in HFCD rat liver or muscle. In addition, the RG attenuated triglyceridemia by inhibition of PPAR-γ and FABP protein expression levels and LXR and SREBP-1 gene expression in liver or muscle. The RG significantly prevented the development of the metabolic disturbances such as hypertriglyceridemia and hyperlipidemia. Taken together, the administration of RG improves hypertriglyceridemia through the alteration in suppression of triglyceride synthesis and accentuated of triglyceride decomposition. These results suggested that RG is useful in the prevention or treatment of hypertriglyceridemia.
Abstract
Korean Red Ginseng (RG) are used as a traditional treatment for improve blood circulation. This experimental study was designed to investigate the inhibitory effects of Korean red ginseng on lipid metabolism in high fat/cholesterol diet (HFCD)-induced hypertriglyceridemia. Sprague Dawley rats were fed the HFCD diet with/without fluvastatin (Flu, positive control) 3 mg/kg/day, and RG 125 or 250 mg/kg/day, respectively. All groups received regular diet or HFCD diet, respectively, for 13 weeks. The last three groups treatment of Flu and RG 125, and RG 250 orally for a period of 9 weeks. Group 1, reular diet; group 2, HFCD diet; group 3, Flu + HFCD diet; group 4, RG 125 + HFCD diet; group 5, RG 250 + HFCD diet. As a result, treatment with low or high doses of RG markedly attenuated plasma levels of triglycerides and augmented plasma levels of high-density lipoprotein (HDL) in HFCD-fed rats. RG and Flu also led to an increase in lipoprotein lipase activity in the HFCD group. On the other hand, RG and Flu led to an decrease in fatty acid synthase and free fatty acid activity in the HFCD group. Treatment with RG suppressed increased expressions of PPAR-α and AMPK in HFCD rat liver or muscle. In addition, the RG attenuated triglyceridemia by inhibition of PPAR-γ and FABP protein expression levels and LXR and SREBP-1 gene expression in liver or muscle. The RG significantly prevented the development of the metabolic disturbances such as hypertriglyceridemia and hyperlipidemia. Taken together, the administration of RG improves hypertriglyceridemia through the alteration in suppression of triglyceride synthesis and accentuated of triglyceride decomposition. These results suggested that RG is useful in the prevention or treatment of hypertriglyceridemia.
참고문헌 (35)
- Kreuzer J, "Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1, 2", FASEB J, 17, pp.T38~T40 (2003)[DOI]
- Krauss RM, "Triglycerides and atherogenic lipoproteins: rationale for lipid management", Am J Med, 105, pp.58S~62S (1998)[DOI]
- Janes PJ, "Meal-frequency effects on plasma hormone concentrations and cholesterol synthesis in human", Am J Clin Nutr, 57, pp.868~874 (1993)[DOI]
- 신현영, "2014년 사망원인 통계", 대한의사협회지, 59(3), pp.221~232 (2016), 대한의사협회[DOI]
- Michael S. Brown, "Harrison's Principles Of Internal Medicine", pp.2058~ (1994), McGraw-Hill
- Watts GF, "Effects on coronary artery disease of lipid lowering diet of diet plus cholestyramine. in the St. Thomas, atherosclerosis regression study (STARS)", Lancet, 339, pp.563~569 (1992)[DOI]
- 신미경, "연잎 건분이 고지방식이를 먹인 흰쥐의 지질 농도에 미치는 영향", 한국식생활문화학회지, 21(2), pp.202~208 (2006), 한국식생활문화학회
- Myung-A Kim, "Triglyceride and Cardiovascular Disease", J Lipid Atheroscler, 2(1), pp.1~8 (2013)[DOI]
- Golan M, "Role of behavior modification in the treatment of childhood obesity with the parents as the exclusive agent of change", Int. J. Obesity, 22, pp.1217~1224 (1998)[DOI]
- Grundy SM, "Hypertriglyceridemia. Atherogenic dyslipidemia, and the metabolic syndrome", Am J Cardiol, 81(4A), pp.18B~25B (1998)[DOI]
- Assmann G, "Relation of high-density lipoprotein cholesterol and triglyceride to incidence of atherosclerotic coronary artery disease(the PROCAM experience). Prospective Cardiovascular Munster study", Am J Cardiol, 70(7), pp.733~737 (1992)[DOI]
- Jang SK, "An Experimental Study on the Effect ofImmunopotential and the Anticancer Effect of Red Ginseng Extract", J Ginseng Res, 18, pp.151~159 (1994)
- Cho JY, "Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation", Planta Med, 68, pp.497~500 (2002)[DOI]
- Lee EJ, "Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1", Th2 differentiation, 2004, pp.4, 235~244
- 안영은, "팽화 홍삼으로부터 20(S)-Ginsenoside Rg3와 Rg5의 분리 및 구조동정", 산업식품공학, 14(2), pp.159~165 (2010), 한국산업식품공학회
- Ki-Seok Choi, "Inhibition of Hydrogen Sulfide-induced Angiogenesis and Inflammation in Vascular Endothelial Cells: Potential Mechanisms of Gastric Cancer Prevention by Korean Red Ginseng", Journal of Ginseng Research, 36(2), pp.135~145 (2012), 고려인삼학회[DOI]
- 박혜민, "Korean red ginseng prevents ethanol-induced hepatotoxicity in isolated perfused rat liver", 대한수의학회지, 51(2), pp.159~164 (2011), 대한수의학회
- Park HM, "Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells", J. Ethnopharmacol., 141, pp.1071~1076 (2012)[DOI]
- Bae EA, "Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models", Biol. Pharm. Bull., 29, pp.1862~1867 (2006)[DOI]
- 최운용, "초고압 증숙처리가 산삼배양근의 진세노사이드 Rg3와 Rh2의 함량에 미치는 영향", 한국약용작물학회지, 20(4), pp.270~276 (2012), 한국약용작물학회[DOI]
- Tokumoto T, "Impact of fluvastatin on hyperlipidemia after renal transplantation", Transplant Proc, 36(7), pp.2141~2144 (2004)[DOI]
- Jorge PA, "Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits", Arq Bras Cardiol, 84(4), pp.314~319 (2005)[DOI]
- 박모라, "뽕잎추출물이 고콜레스테롤 식이 흰쥐의 지질대사에 미치는 영향", 한국식품영양과학회지, 36(1), pp.43~50 (2007), 한국식품영양과학회
- Rade N. Pejic, "Hypertriglyceridemia", JABFM, 19(3) (2006)
- Krauss RM, "Triglycerides and atherogenic lipoproteins: rationale for lipid management", Am J Med, 105, pp.58S~62S (1998)[DOI]
- Eberle D, "SREBP transcription factors: master regulators of lipid homeostasis", Biochimie, 86(11), pp.839~848 (2004)[DOI]
- Zhang Y, "Liver <TEX>$LXR{\alpha}$<", TEX> expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice, 2012, pp.122(5), 1688~1699
- Wang G, "Recent insights into the biological functions of liver fatty acid binding protein 1", J Lipid Res, 56(12), pp.2238~2247 (2015)[DOI]
- Newberry EP, "Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice", Hepatology, 44(5), pp.1191~1205 (2006)[DOI]
- Edvardsson U, "PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes", J Lipid Res, 47(2), pp.329~340 (2006)[DOI]
- Nevin DN, "The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity", Arterioscler Thromb, 14(6), pp.869~873 (1994)[DOI]
- Wung SF, "The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion", Lipids Health Dis, 5, pp.19~ (2006)[DOI]
- Sozio MS, "Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells", Am J Physiol Gastrointest Liver Physiol, 301(4), pp.G739~G747 (2011)[DOI]
- Lee WH, "AMPK-Dependent Metabolic Regulation by PPAR Agonists", PPAR Research, 549101, pp.10~ (2010)
- Zhang BB, "AMPK: an emerging drug target for diabetes and the metabolic syndrome", Cell Metab, 9, pp.407~416 (2009)[DOI]